These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 20142449)

  • 21. [Physiopathology of giant cell arteritis: From inflammation to vascular remodeling].
    Régent A; Ly KH; Mouthon L
    Presse Med; 2019 Sep; 48(9):919-930. PubMed ID: 31543394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System.
    Strehl C; Ehlers L; Gaber T; Buttgereit F
    Front Immunol; 2019; 10():1744. PubMed ID: 31396235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
    Ly KH; Régent A; Tamby MC; Mouthon L
    Autoimmun Rev; 2010 Aug; 9(10):635-45. PubMed ID: 20457278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Giant-cell arteritis pathogenesis].
    Samson M; Bonnotte B
    Presse Med; 2012 Oct; 41(10):937-47. PubMed ID: 22902103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
    Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
    Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionally distinct IFN-γ
    Chen YH; Eskandarpour M; Gondrand A; Zhang X; Gu R; Galatowicz G; Lightman SL; Calder VL
    Eur J Immunol; 2020 Dec; 50(12):1941-1951. PubMed ID: 32652562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are IL-10+ regulatory Th17 cells implicated in the sustained response to glucocorticoid treatment in patients with giant cell arteritis? Comment on the paper of Espigol-Frigole et al.
    Samson M; Audia S; Janikashvili N; Bonnotte B
    Ann Rheum Dis; 2013 May; 72(5):e3. PubMed ID: 23475980
    [No Abstract]   [Full Text] [Related]  

  • 28. Mucosal-associated invariant T cells in Giant Cell Arteritis.
    Ghesquière T; Ciudad M; Ramon A; Greigert H; Gerard C; Cladière C; Thébault M; Genet C; Devilliers H; Maurier F; Ornetti P; Quipourt V; Gabrielle PH; Creuzot-Garcher C; Tarris G; Martin L; Soudry-Faure A; Saas P; Audia S; Bonnotte B; Samson M
    J Autoimmun; 2021 Jul; 121():102652. PubMed ID: 34000675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.
    Hernández-Rodríguez J; Segarra M; Vilardell C; Sánchez M; García-Martínez A; Esteban MJ; Queralt C; Grau JM; Urbano-Márquez A; Palacín A; Colomer D; Cid MC
    Rheumatology (Oxford); 2004 Mar; 43(3):294-301. PubMed ID: 14679293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures.
    Blain H; Abdelmouttaleb I; Belmin J; Blain A; Floquet J; Guéant JL; Jeandel C
    J Gerontol A Biol Sci Med Sci; 2002 Apr; 57(4):M241-5. PubMed ID: 11909890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.
    Ciccia F; Alessandro R; Rizzo A; Principe S; Raiata F; Cavazza A; Guggino G; Accardo-Palumbo A; Boiardi L; Ferrante A; Principato A; Giardina A; De Leo G; Salvarani C; Triolo G
    Arthritis Rheum; 2011 Jul; 63(7):2097-104. PubMed ID: 21452292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses.
    Sullivan JA; Jankowska-Gan E; Shi L; Roenneburg D; Hegde S; Greenspan DS; Wilkes DS; Denlinger LC; Burlingham WJ
    Am J Transplant; 2014 Jul; 14(7):1512-22. PubMed ID: 24866539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in our understanding of giant cell arteritis pathogenesis.
    Samson M; Corbera-Bellalta M; Audia S; Planas-Rigol E; Martin L; Cid MC; Bonnotte B
    Autoimmun Rev; 2017 Aug; 16(8):833-844. PubMed ID: 28564617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IL-17 pathway as a target in giant cell arteritis.
    Zeisbrich M; Thiel J; Venhoff N
    Front Immunol; 2023; 14():1199059. PubMed ID: 38299156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice.
    Chai H; Yang L; Gao L; Guo Y; Li H; Fan X; Wu B; Xue S; Cai Y; Jiang X; Qin B; Zhang S; Ke Y
    Transplantation; 2014 Oct; 98(7):729-37. PubMed ID: 25093516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD28 Signaling Controls Metabolic Fitness of Pathogenic T Cells in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Nadler SG; Goronzy JJ; Weyand CM
    J Am Coll Cardiol; 2019 Apr; 73(14):1811-1823. PubMed ID: 30975299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage.
    Boniface K; Blumenschein WM; Brovont-Porth K; McGeachy MJ; Basham B; Desai B; Pierce R; McClanahan TK; Sadekova S; de Waal Malefyt R
    J Immunol; 2010 Jul; 185(1):679-87. PubMed ID: 20511558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis.
    Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T
    Arthritis Res Ther; 2019 Dec; 21(1):304. PubMed ID: 31888748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased IFN-γ-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease.
    Xu W; Li R; Sun Y
    BMC Pulm Med; 2019 Jul; 19(1):137. PubMed ID: 31349846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.